13.1 Oncologic Emergencies I: Spinal Cord Compression, Hypercalcemia, Tamponade & SVC Syndrome

Overview

Metastatic breast cancer frequently involves bone, pleura, pericardium, and mediastinal nodes, so breast care nurses must recognize structural and metabolic emergencies quickly, often by phone triage. Hypersensitivity reactions, sepsis, malignant pleural effusion, and thromboembolism are covered in the next section; febrile neutropenia and extravasation are covered with chemotherapy toxicities.

Oncologic Emergencies in Breast Oncology

Certified breast care nurses must recognize and respond to these four structural and metabolic emergencies immediately:

1. Malignant Spinal Cord Compression (MSCC)

Occurs in 5% to 10% of patients with advanced metastatic breast cancer, arising when vertebral bone metastases expand into the epidural space, mechanically compressing the thecal sac and spinal cord (thoracic spine ~70%, lumbosacral ~20%, cervical ~10%):

• Clinical Presentation: Progressive back pain is the initial symptom in >95% of cases. Crucially, MSCC back pain worsens when recumbent (lying supine in bed) due to distention of the epidural venous plexus and is exacerbated by coughing, straining, or percussion. Subsequent signs include motor weakness (difficulty ambulating, leg "heaviness"), sensory impairment with a distinct sensory level, and late autonomic dysfunction (urinary retention, overflow incontinence, loss of anal sphincter tone).
• Emergency Nursing Management: Immediate administration of high-dose intravenous dexamethasone (10 to 16 mg IV bolus followed by 4 to 8 mg every 6 hours) to reduce vasogenic cord edema; emergent MRI of the entire spine within 24 hours (skip lesions occur in up to 30% of patients); urgent radiation oncology and spine surgery consultation for emergent decompression and stabilization.

2. Hypercalcemia of Malignancy (HCM)

One of the most common metabolic emergencies in metastatic breast cancer, especially with extensive bone metastases, mediated by tumor secretion of parathyroid hormone-related peptide (PTHrP) or osteolytic bone destruction:

• Clinical Manifestations: "Bones, stones, abdominal groans, and psychic moans." Anorexia, nausea, vomiting, severe constipation, polyuria, polydipsia, dehydration, muscle weakness, confusion, delirium, stupor, and cardiac dysrhythmias (shortened QT interval).
• Diagnostic Metric: Corrected Calcium = Measured Serum Calcium + [0.8 × (4.0 - Serum Albumin)]. A corrected calcium >10.5 mg/dL is abnormal; >14.0 mg/dL represents a life-threatening crisis.
• Emergency Protocols:
  • Aggressive Hydration: Immediate infusion of 0.9% normal saline at 200 to 500 mL/hr to restore intravascular volume and promote renal calciuresis.
  • Antiresorptive Therapy: Intravenous zoledronic acid (4 mg over 15 minutes) or subcutaneous denosumab (120 mg on days 1, 8, 15, then monthly; preferred in renal insufficiency). Onset is 48 to 72 hours.
  • Calcitonin: Subcutaneous/IM calcitonin (4 to 8 IU/kg every 12 hours) provides rapid calcium reduction within 2 to 4 hours (tachyphylaxis occurs after 48 hours).
  • Loop Diuretics: Furosemide is strictly indicated only after complete intravascular volume rehydration is achieved and fluid overload threatens.

3. Malignant Pericardial Effusion and Cardiac Tamponade

Metastatic seeding of the pericardium leads to rapid fluid accumulation, restricting ventricular filling. Manifests with Beck's triad (hypotension, jugular venous distention, and distant/muffled heart sounds), tachycardia, dyspnea, and pulsus paradoxus (>10 mmHg systolic drop on inspiration). Managed via emergent pericardiocentesis or surgical pericardial window.

4. Superior Vena Cava (SVC) Syndrome

Extrinsic compression of the superior vena cava by mediastinal lymphadenopathy or tumor thrombus impairs venous return from the head, neck, and upper extremities. Manifests as progressive facial and periorbital edema, plethora, distended neck and thoracic veins, dyspnea, and cough. Managed with head-of-bed elevation, supplemental oxygen, emergency radiation therapy, or endovascular stenting.

Emergency Summary Table

Additional Management Details

Spinal Cord Compression

• Outcome predictor: patients who walk at diagnosis usually keep walking after treatment; patients who are paraplegic for more than about 24 to 48 hours rarely recover. This is why triage must be same-day.
• Definitive treatment: radiation is standard (for example, a single 8-Gy fraction or 20 Gy in 5 fractions for patients with limited survival); decompressive surgery followed by radiation benefits selected patients with a single level of compression, spinal instability, or radioresistant disease.
• Nursing care: spinal precautions and log-rolling if instability is suspected, frequent neurologic checks (motor strength, sensory level, bowel and bladder function), bladder scanning for retention, bowel regimen, VTE prophylaxis, pain control, and steroid side-effect monitoring (hyperglycemia, gastric protection, mood changes).

Hypercalcemia of Malignancy

• Mechanisms: PTH-related peptide secretion (humoral hypercalcemia) and osteolytic bone metastases are the main causes in breast cancer.
• Rehydration goal: isotonic saline to restore volume and maintain a brisk urine output (commonly around 100 to 150 mL per hour), with careful monitoring in heart or kidney disease.
• Bone-modifying agents: zoledronic acid (used with caution and close creatinine monitoring in renal impairment) or denosumab, which is not cleared by the kidneys but carries a higher risk of hypocalcemia. Calcium falls over 2 to 4 days, so calcitonin bridges the first 48 hours.
• Monitoring: calcium, albumin, creatinine, magnesium, and phosphorus; mental status; strict intake and output; fall precautions.
• Prevention: in patients with bone metastases, regular bone-modifying agents reduce skeletal-related events, and patients should stay hydrated and mobile.

Malignant Pericardial Effusion and Tamponade

Breast and lung cancers are the most common solid tumors causing malignant pericardial effusion. Slowly accumulating fluid may cause only fatigue and dyspnea until tamponade develops. Echocardiography confirms the diagnosis. After pericardiocentesis, recurrence is common, so a pericardial drain, pericardial window, or sclerosis may follow. Nurses monitor vital signs, pulsus paradoxus, drain output, and signs of reaccumulation.

Superior Vena Cava Syndrome

SVC syndrome is less common in breast cancer than in lung cancer or lymphoma but can occur with mediastinal nodal disease or catheter-related thrombosis. Most cases develop over weeks and are urgent rather than immediately life-threatening, unless there is airway compromise or cerebral edema. Endovascular stenting gives the fastest symptom relief; radiation and systemic therapy treat the underlying tumor, and anticoagulation is used for thrombosis. Avoid blood pressure measurements and IV access in the arms when upper-extremity venous flow is obstructed.